Jean-Pascal Fournier is a family physician in the Academic Department of Family Medicine, University of Nantes (France), and a researcher at SPHERE since 2020. He received his Ph.D. in pharmacology in 2013 (University of Toulouse) and has been a postdoctoral fellow in pharmaco-epidemiology at McGill University, Montreal, between 2013 and 2014. He specialized in enhancing quality of medication prescribing and safety of medication use in primary care. His current focus at SPHERE is on the evaluation of deprescribing processes and patients’ attitudes towards deprescribing.
Suitability of patient education materials on proton pump inhibitors deprescribing: a focused review.
Nguyen-Soenen J, Rat C, Fournier JP.
Processes and determinants of integration of eGFR in physicians' drug prescriptions: a qualitative study of semi-structured interviews.
Lefèvre L, Jourdain M, Fournier JP.
Effects of discontinuation of urate-lowering therapy : a systematic review.
Beslon B, Moreau P, Maruani A, Maisonneuve H, Giraudeau B, Fournier JP.
Tramadol for noncancer pain and the risk of hyponatremia.
Fournier JP, Yin H, Nessim SJ, Montastruc JL, Azoulay L.
Metformin and low levels of thyroid-stimulating hormone in patients with type 2 diabetes mellitus.
Fournier JP, Yin H, Hoi Yun Yu O, Azoulay L.
DES in Primary care